Anticipated to reach a valuation of US$ 39.9 Billion by the close of 2022, the Global Cold Cough And Sore Throat Remedies Industry is poised for further expansion. Forecasts indicate a steady growth trajectory with a Compound Annual Growth Rate (CAGR) of 0.6% from 2022 to 2032, ultimately achieving a valuation of US$ 37.7 Billion …